Today, a well-known doctor published this news without providing alternative solutions or answering patients' questions. The result? Panic among those who cannot do without levothyroxine.
What should we do?
In your opinion, how true is what he claims? Does natural desiccated thyroid (NDT) pose less risk to bones compared to levothyroxine? Thank you.
This is what he wrote:
The Impact of Prolonged Levothyroxine Use on Bone Health and Cardiovascular Risks
It has been highlighted that the prolonged use of levothyroxine may increase the risk of developing osteopenia. Levothyroxine, a medication commonly prescribed for hypothyroidism, has recently been linked to a greater loss of bone mass in elderly patients, even in those with normal thyroid function.
What Risks Do You Face?
Bone Mass Loss:
The use of levothyroxine can lead to a significant reduction in bone density, increasing the risk of osteopenia and osteoporosis, particularly in older adults.
Excess Thyroid Hormones:
Excess levothyroxine can have catabolic effects, not only on bones but also on other tissues, causing reabsorption of the bone's mineral and organic components. This excessive reabsorption can weaken the bones and contribute to bone mass loss.
Cardiovascular Risks:
Excess thyroid hormones can also affect the cardiovascular system, increasing the risk of arrhythmias and fluctuations in blood pressure, particularly in older adults.
It has long been known that an excess of levothyroxine may lead to bone mass loss. Excess thyroid hormones exert a catabolic effect on body tissues, leading to excessive bone resorption. This not only affects the bones but also poses a threat to the cardiovascular system, increasing the risk of arrhythmias and cardiovascular imbalances, especially in older individuals.
The Study
A study was conducted on 81 euthyroid patients undergoing levothyroxine therapy, compared to a control group of 364 volunteers. The participants, aged 65 and older, had consistently normal thyroid function and were monitored over a period of 6.3 years. The results revealed a greater loss of bone mass and density in patients receiving levothyroxine therapy compared to the control group.
This evidence underscores the importance of careful monitoring of thyroid hormone levels, particularly in elderly patients, to prevent excessive bone loss and reduce the risk of osteopenia, osteoporosis, and cardiovascular complications.